lar treatments has grown steadily since their introduction. [4] [5] [6] 10, 20 Andaluz and Zuccarello 1 reported that from 1993 to 2003, the number of aneurysm clipping procedures remained stable, whereas the number of endovascular procedures had doubled.
Increased focus on health care expenditures and cost effectiveness prompted multiple investigators to compare costs of endovascular coil embolization to open clipping of cerebral aneurysms. 3, 11, [13] [14] [15] [16] 25, 28 Financial analysis of the ISAT revealed significantly greater costs associated with endovascular treatment. 22 Other reviews of administrative databases have found greater costs with coil embolization. 3, 11, 13, 16 Hoh et al., 14 reviewing an administrative database and attempting to control for patient and facility variables, reported greater charges with open aneurysm ligation, with clipping resulting in $15,325 more in total charges for patients with ruptured aneurysms as well as $11,263 more in total charges for unruptured cases.
Previous reports on health policy have focused on regional variations in health care spending and resource utilization. Fisher et al. 7 reported on regional variation in Medicare expenditures and noted that physician factors must play a predominant role in variation in health care expenditures. Limited research has been conducted on regional variation in adoption of new technology. Geographic heterogeneity in acceptance of new technologies may provide another potential explanation for regional variation in health care costs.
This study reviews the NIS database from 2002 to 2008 that is maintained by the AHRQ. The NIS database is the largest all-payer inpatient database in the US. The NIS was developed as part of the Healthcare Cost and Utilization Project, a federal-state-industry partnership sponsored by the AHRQ. As of 2008, the NIS contains all discharge data from 1056 hospitals located in 42 states, a stratified sample representing approximately 20% of US hospitals.
Using data from the NIS, this study focuses on trends in the US of open clipping versus endovascular coiling of both ruptured and unruptured aneurysms. Costs between procedures as well as geographical cost differences in hospitals were noted. We attempt to show the regional impact of the growing adoption of endovascular treatment for cerebral aneurysms by investigating trends in utilization and cost across the US.
Methods

Data Selection and Outcome Variables
The NIS databases were obtained from the AHRQ's Healthcare Cost and Utilization Project. This database represents approximately 20% of patient admissions every year at nonfederal hospitals. Results were investigated from 2002 through 2008, the last year with available data.
Hospitalization patient records were cross-matched by ICD-9 codes for SAH (430) or unruptured cerebral aneurysm (437.3) along with procedure codes for aneurysmal clipping (39.51) and coiling (39.79, 39.72, or 39.52) in the NIS database. Results were imported into a MySQL database for querying. Selection of these aneurysm codes has been previously validated.
12-14
The NIS hospitalization data on adult patients (18 years of age or older) with SAH and unruptured aneurysms were compiled. The 2 cohorts (aneurysms presenting with SAH and presenting unruptured) were compared against one another for 4 primary end points-in-hospital death, hospital LOS, total hospital cost, and selected procedure. Hospital costs were adjusted to bring all costs to 2008 equivalents through application of an assumed 3% per year inflation factor.
We excluded patients who were listed with procedure codes for both clipping and coiling, and those who received diagnosis codes for both an unruptured aneurysm and SAH. Regression analysis was performed for fixedeffect variables including age, sex, race, number of procedures, number of diagnoses, nonelective procedure, and year of surgery. Patients who died in the hospital were excluded from the LOS estimation. We examined the choice of operation (clipping or coiling) in the context of patient demographics, comorbidities, and presenting diagnosis.
Hospital location by state was treated as a random effect; we analyzed the variability across states and plotted the geographic results. The standard errors of random effects were estimated (function se.ranef, the "arm" package in the R programming language) and the 95% CIs were calculated. States with a CI outside the population mean were noted and tabulated.
Statistical Analysis
Statistical analysis was performed using the lme4 package (version 0.999375-33) in the R programming language for statistical computing (version 2.11.0), both available under the GNU Public License (http://www. cran.r-project.org). The variables death and choice of treatment were used for logistic regression analysis. Length of stay was analyzed assuming a Poisson distribution accounting for overdispersion, with greater variance than expected in a Poisson variable. The total cost was analyzed using a linear regression in which LOS was treated as a fixed effect measured as cost per day. Random effect of state was modeled as a baseline effect on costs and a cost per day during LOS. All factors of interest were included and parsimonious models were found by systematically removing the least significant factor and recalculating the model.
Results
Clipping and Coiling Rates in SAH Versus Unruptured Aneurysms
We found 27,180 patients who presented with cerebral aneurysms. Of these patients, 1696 who had both ruptured and unruptured aneurysms were excluded. Additionally, 477 patients treated with both endovascular and clipping procedures and 813 who did not have SAH or an unruptured cerebral aneurysm as their primary diagnosis were omitted. These exclusions and omissions resulted in patient cohorts of 12,588 SAH cases (7318 clipped and 5270 coiled aneurysms) compared with 11,606 unruptured ce-rebral aneurysm cases (5216 clipped and 6390 coiled aneurysms). Assuming a representative cohort sample, the NIS offers a representative sample of more than 120,000 patients with aneurysms.
Linear mixed regression analysis of the selected procedure (clipping or coiling) for SAH and unruptured aneurysms found that the likelihood of a clipping procedure decreased over time for both patient populations, and the total number of patients receiving coil embolization increased from 17.28% to 57.59% (SAH cases) and 29.70% to 62.73% (unruptured aneurysm cases), respectively (p < 0.0001; Fig. 1 ).
Increasing age was associated with an increase in the rate of aneurysmal coiling versus clipping (p < 0.00001; Fig. 2 ). An increased likelihood of undergoing a coiling procedure was observed in patients who had peripheral vascular disease and more recent procedures (p < 0.0001). The odds of undergoing clipping were higher in patients with comorbidities such as hypertension, diabetes mellitus, and electrolyte abnormalities. In patients with SAH the association between age and coiling procedures was reduced. Comorbidities such as CHF, diabetes mellitus, electrolyte abnormalities, and whether the procedure was elective increased the likelihood of undergoing a coiling procedure. Other factors found to affect the choice of procedure are summarized in Table 1 . Regionally, the greatest increase in utilization of endovascular techniques in the US was found along the western coastline and in the northeast. The percentage of coiling procedures compared with clipping procedures has steadily increased in these areas. National ORs suggest that Arizona and Iowa have substantially higher likelihoods of clipping versus coiling procedures (OR 8.086, 95% CI 3.517-18.586, and OR 7.180, 95% CI 4.178-12.344, respectively). Missouri, Oklahoma, Virginia, California, New York, and Tennessee also demonstrated greater rates of clipping versus endovascular treatment (Table 2) . States with greater likelihoods of endovascular treatment included Arkansas, Indiana, Kansas, Michigan, New Hampshire, and Texas. Geographic changes in ORs per year in coiling procedures reveal significant declines in the likelihood of clipping procedures in Arizona, Iowa, Missouri, Oklahoma, South Carolina, Virginia, and Wisconsin (Table 3) . Of the 20 states east of the Mississippi River in which 2008 NIS data were available, 13 (65%) featured endovascular treatment incidences of 50% or greater. Sixteen states in the remainder of the nation had appropriate representation in the 2008 NIS sample and 6 (37.5%) of these featured greater than 50% incorporation of endovascular approaches.
Patients Presenting With SAH
Patients presenting with SAH had a higher likelihood of comorbidities such as anemia, coagulopathy, CHF, and electrolyte abnormalities. African American, Hispanic, and Asian patients were more likely to present with SAH. Demographic data on patients presenting with SAH are reviewed in Table 4 . From 2002 to 2008, the incidence of patients presenting with SAH declined from 60.04% to 45.17% (p < 0.00007; Fig. 4 ). Geographic variation in patient presentation is also reviewed in Table 4 ; there were few geographic outliers with regard to presentation with SAH (5 states).
Fixed-Effects Analysis of In-Hospital Mortality Rates
The rate of in-hospital deaths declined for patients with either SAH or unruptured cerebral aneurysms over the time period, from 15.75% to 13.56% and from 1.90% to 0.39%, respectively (p < 0.00001). Odds ratios for fixed effects on in-hospital mortality rates with respect to coiling versus clipping procedures were analyzed using parsimonious models including age, year of procedure, SAH, and number of procedures and diagnoses ( Table  5 ). The greatest single predictor of in-hospital death was presentation with SAH (OR 38.06, 95% CI 21.84-66.41; p < 0.00001). A coiling procedure increased the odds of death overall, but this is likely confounded by the large increase in death within the SAH patient population (p = 0.0001). Analysis of geographic random effects found no significant differences in in-hospital mortality rates.
Length of Stay
Patients with SAH and unruptured cerebral aneurysms had median LOS calculated for both clipping and coiling procedures. In patients with SAH, median LOS was 16 days regardless of treatment. In patients with unruptured cerebral aneurysms, median LOS declined by 1 day, from 5 to 4 days in the clipping group and from 2 to 1 day in the coiling group, over the years 2002 to 2008. Quasi-Poisson regression analysis was performed to evaluate the fixed effects of age, SAH, number of diagnoses and procedures, race, and year of procedure (Table 6 ). Subarachnoid hemorrhage significantly increased LOS, while endovascular treatment decreased LOS. Age, number of diagnoses including comorbidities (such as hypertension, CHF, and electrolyte disturbances), and number of procedures performed each increased the likelihood of longer median LOS in all patients with aneurysms. Other factors are reviewed in Table 6 . Geographic random effect analysis found a lower median LOS in patients living in the states of California, Colorado, Michigan, and Missouri, whereas patients in Connecticut, Tennessee, Texas, and Virginia had a longer median LOS (Table 6 ).
Institutional Variation in Total Treatment Cost
Variation in total hospital costs for patients with cerebral aneurysms was analyzed based on institutional category using NIS facility distinctions (rural, urban and private, or urban and academic). While yearly fluctuations in hospital charges were found, there were evident general trends toward greater expenditures over time. 
Factors Affecting Total Hospital Charges
Fixed-effects analysis was performed on variables including comorbidities, race, number of procedures, year of procedure, coil embolization, and death on total cost for patients with unruptured cerebral aneurysms or SAH. Patients with neurological disease and coagulopathy showed increases in total cost by $103,821.99 and $26,556.74, respectively (p < 0.001), whereas peripheral vascular disease lowered total costs by $9500.95. Presentation with SAH increased overall hospital costs by $7187, a difference that was not statistically significant (p = 0.24).
Assessing the raw data from the NIS database, endovascular treatment increased total hospital costs by more than $25,000 (p < 0.001; Table 7 ). Death increased total hospital charges by $28,471.88 (p = 0.003), which likely arises from the resources demanded of patients presenting with SAH. Elective treatment lowered costs by $6234.75 (p = 0.001), regardless of all other factors. The year the procedure was performed increased hospital charges by $4326.68 (p < 0.001), reflecting trends in rising health care costs outpacing the inflation correction used in the analysis. Individual factors contributing to an increase or decrease in hospital costs are reviewed in Table 7 .
Stratifying patients by diagnosis revealed clear parallel increases in total hospital charges, with the greatest contributor to increased cost demonstrated as presentation with SAH. The cost curves for both endovascular and open surgical treatments increased over time, with no significant differences between the 2 cohorts (Fig. 4) . While overall assessment of the cohort showed greater charges in endovascularly treated patients, analysis of patients with SAH receiving clipping or coiling revealed coiling to be cost effective, lowering hospital charges by $19,578.84 (p < 0.001). Multiple procedures performed on patients with SAH were associated with an increase in cost of $3709.30 (p < 0.001). The total cost for treating patients with SAH also increased by $2625.76 (p < 0.001) over the 6-year period (Table 7) .
Geographical Variation in Total Treatment Cost and Trends in Treatment Cost
Geographic random effect impact on total hospital cost was modeled as both a cost per day and a net "admission cost," which was a sum added to other hospital expenditures. States whose costs diverged from the national mean were identified if the 95% CI of the random effects did not reach zero. Methodological issues in the use of NIS data may entail regional sampling differences, a potential source of bias. Examination of the random effects on cost by state revealed that Pennsylvania and California were consistently more expensive per hospital admission and per day. Arizona, Iowa, New York, and Tennessee were less expensive per admission and per day. Geographic outliers in total costs and daily costs are reviewed in Table 8 .
Discussion
Financial Impact of Endovascular Therapy
Few studies have compared the cost of endovascular treatment to open surgery for patients with aneurysms in the US. 13, 14, 22 Maud et al. 22 estimated the cost of initial hospitalization, disability, angiography, retreatment, and rebleeding for patients with SAH using utilization data from the Premier Perspective Comparative Data- base. They applied these values to data obtained from the ISAT to calculate and compare US cost estimates for patients treated with either endovascular coiling or surgical clipping. The average 1-year total cost per patient with a ruptured intracranial aneurysm treated by coiling was $45,493, whereas the average 1-year cost per patient treated by clipping was significantly lower at $41,769. They concluded that although coiling had better outcomes at 1 year, it resulted in higher costs directly related to a higher incidence of retreatment. 14 examined the total hospital cost and LOS for patients with unruptured and ruptured aneurysms. This study used NIS data from 2002 to 2006. After adjusting for the effects of patient-and hospital-specific factors, clipping was associated with significantly longer LOS and significantly higher total hospital costs for patients with ruptured and unruptured aneurysms. Surgical clipping was associated with an average of 1.2-times more days in hospitalization for ruptured aneurysms and an average of 1.8-times more days in hospitalization for those with unruptured aneurysms. In addition, clipping resulted in $15,325 more in total charges for patients with ruptured aneurysms as well as $11,263 more in total charges for patients with unruptured aneurysms.
Trends and Geographic Variations in Health Care Expenditures
Medicare spending, after adjusting for inflation, has risen annually by 3.5% per year from 1992 to 2006. Cost increases have not been uniform, and considerable differences have been noted across regions. A report by Fisher et al. 7 notes that in large Eastern metropolitan areas such as Miami, Florida; Long Island, New York; and Boston, Massachusetts, increases in Medicare spending have averaged up to 5.0% per year. Other similar areas, such as Salem, Oregon, and San Francisco, California, have much lower rates of health care cost inflation with rates of approximately 2.3% to 2.4%.
An explanation for this discrepancy in health care spending is not evident. High cost areas in the country are also associated with high growth and also slight differences in the malpractice environment. Previous reports note that regional differences in health care costs could only explain approximately 10% of state variations in Medicare expenditures.
2,7 Physician behavior may explain some cost discrepancies. In higher spending regions, primary care physicians are reported to be more likely to recommend discretionary services such as referrals to treat general diseases, and all physicians were more aggressive with admissions to ICUs. 27 In regions with more physicians and hospital beds, data show that patients make more visits to physicians and experience more hospitalizations. 8, 9 The local health care environment profoundly influences health care resource capacity and access, and thus may impact clinical decision making.
A primary assumption in ascribing regional variations in health care costs to physician behavior is uniform availability of technology. Fisher et al. 7 note that variation in availability of clinical technology does not explain cost variation nationwide, noting further that all US residents have access to the same technology. It has not been demonstrated that all US citizens have uniform access to new technologies.
Results of the Present Study
Our findings demonstrate an increase in percentage of cerebral aneurysms treated endovascularly from 2002 to 2008 for both SAH (17.28% to 57.59%) and unruptured aneurysms (29.70% to 62.73%; p < 0.0001; Fig. 1 ). Geographic trends across the US with the greatest increase in endovascular coiling were predominantly east of the Mississippi River and along the west coast (Fig. 3) . In the cohort of states east of the Mississippi River in which 2008 NIS data were available, 65% had predominant use of endovascular techniques in treatment of cerebral aneurysm patients, while only 37.5% of states with adequate data in the remainder of the nation featured greater than 50% use of endovascular approaches. While there has been steady growth of endovascular techniques nationwide, the pattern of this growth is not uniform and significant regional variations are evident.
Length of stay remained constant for SAH from 2002 to 2008 for patients treated with either clipping or coiling, while patients with unruptured aneurysms saw LOS decrease by an average of 1 day. Patients who underwent aneurysmal coiling procedures for either SAH or unruptured aneurysms experienced significantly shorter LOSs overall compared with those who underwent clipping procedures.
While presentation with SAH did not, in isolation, increase hospital costs in a statistically significant fashion, many sequelae of SAH captured by the NIS database may be associated with increased health care expenditures. Subarachnoid hemorrhage was strongly correlated with in-hospital death, which increased the total hospital cost by more than $28,000 (p < 0.003). High-grade SAH may be modeled in the NIS by capture of patients presenting with neurological deficits; presence of neurological comorbidities in our analysis correlated with an increase in total hospital charges of $103,822 (p < 0.00001).
Based on this assessment of NIS data, patient presentation and site of clinical service have greater impact on overall hospital charges than choice of endovascular or open surgical treatment of cerebral aneurysms. This likely explains previous disagreements in the literature with regard to economic impact of endovascular therapy, and may explain the relative cost savings offered by choice of endovascular treatment in patients presenting with SAH. 6, 13, 14, 16, 22, 25 
Geographic Variation and Trends in the Treatment of Cerebral Aneurysms
There are significant regional differences in the incorporation of endovascular treatment of cerebral aneurysms. While the overall percentage of patients with an- These data may suggest that access to endovascular therapy may be lower in some areas, or that some regions are less receptive to transition to endovascular approaches. These differences do not conform to general population distributions, with some very large states showing evidence of low incorporation of endovascular treatment. In patients presenting with SAH, endovascular treatments increase in incidence with transition from rural to urban settings (p = 0.009) and increase further when comparing urban private and urban academic facilities (p = 0.05). Urban academic facilities overall have the highest costs recorded for patients with cerebral aneurysms (p = 0.0006).
The geographic disparity in use of endovascular therapies may illustrate significant regional variation in both the availability and utilization of new technologies. Over the time period studied, endovascular therapies may be considered to have matured, with publication of the ISAT trial, training of more practitioners in endovascular techniques, and wider acceptance of endovascular therapy by the neurosurgical community. 23 The heterogeneity of adoption of endovascular techniques may question the assumption that all US residents have access to the same medical technologies. Geographic variation in technology availability and accessibility may occur; uniform access to endovascular therapies is not evident from this assessment.
This assessment found significant geographic variation in hospital costs for treatment of cerebral aneurysms. Total hospital costs for both SAH and unruptured aneurysms were found to be significantly lower at rural hospitals compared with both private and academic urban hospitals. By state, Pennsylvania and California had the highest costs per admission. There were other outlier states with significant differences from median hospital cost values (Table 8) .
Sources for Bias
Despite the size of the NIS, it remains merely a retrospective database. None of the patients whose data are summarized in the database were randomized, and no effort was made to ensure equal numbers of patients were included in each group of studied categories. Not all states participate in the NIS, and not all hospitals in each state participate in the NIS. The data sample is limited to the hospitals that report and is a reflection of their operative trends. While it may be assumed that this is a representative cross-section of the US health care market, sampling error may occur. This assessment assumes the accuracy of hospital coding data.
Regional variations from states with limited representation in the NIS may skew geographical data. States with no hospitals participating in the NIS assessment are necessarily omitted from the analysis. The database relies on accuracy and standardization of reporting from individual hospitals; regional variation in reporting methodology could occur.
The very large study sample values presented in the NIS and other administrative database studies increase the likelihood of achieving statistical significance with nonsensical relationships. For instance, in this assessment of the NIS database we found that the Asian patients undergoing clipping procedures were significantly less expensive than non-Asians or Asians treated endovascularly (p = 0.04). The clinical relevance of this finding is questionable. With NIS and other database studies, appropriate study design and critical assessment of results are necessary to provide database relationships with context, meaning, and relevance.
endovascularly. The greatest impact on patient mortality was presentation with SAH. Differences in hospital costs between open and endovascular techniques are likely secondary to the presenting diagnosis of the patient and site-of-service factors. Presentation with SAH indirectly had a significant impact on hospital cost, and a greater percentage of endovascular procedures were completed at urban academic medical centers. There is substantial regional variation in adoption of endovascular techniques. These variations may question previous assumptions with regard to the uniformity of availability of technology in the US health care system. Geographical differences in the implementation of new technology may affect overall regional health care expenditures.
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